Cleared Traditional

K162027 - TRAcelet Compression Device

K162027 is an FDA 510(k) clearance for TRAcelet Compression Device, manufactured by Medtronic Vascular. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K162027 · Medtronic Vascular · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2016
Decision
91d
Days
Class 2
Risk

K162027 is an FDA 510(k) clearance for the TRAcelet Compression Device. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Medtronic Vascular (Danvers, US). The FDA issued a Cleared decision on October 21, 2016 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtronic Vascular devices

FDA 510(k) Submission Details - K162027

510(k) Number K162027 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2016
Decision Date October 21, 2016
Days to Decision 91 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 125d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 150
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K162027.
ChitoPulse 9in / 23 cm, ChitoPulse 12in / 30.5 cm, ChitoPulse 15in / 38 cm
K170958 · Tricol Biomedical, Inc. · Aug 2017
IntraClude Intra-Aortic Occlusion Device
K163693 · Edwards Lifesciences, LLC · Jan 2017
PreludeSYNC Radial Compression Device
K162988 · Merit Medical Systems, Inc. · Jan 2017
Vein Clamps, Artery Clamps
K161315 · Aros Surgical Instruments Corporation · Aug 2016
VasoStat Hemostasis Device
K153259 · Forge Medical, Inc. · Jan 2016
TR BAND Radial Compression Device
K152525 · Terumo Medical Corporation · Nov 2015